-
Do Histopathological Foundation Models Eliminate Batch Effects? A Comparative Study
Authors:
Jonah Kömen,
Hannah Marienwald,
Jonas Dippel,
Julius Hense
Abstract:
Deep learning has led to remarkable advancements in computational histopathology, e.g., in diagnostics, biomarker prediction, and outcome prognosis. Yet, the lack of annotated data and the impact of batch effects, e.g., systematic technical data differences across hospitals, hamper model robustness and generalization. Recent histopathological foundation models -- pretrained on millions to billions…
▽ More
Deep learning has led to remarkable advancements in computational histopathology, e.g., in diagnostics, biomarker prediction, and outcome prognosis. Yet, the lack of annotated data and the impact of batch effects, e.g., systematic technical data differences across hospitals, hamper model robustness and generalization. Recent histopathological foundation models -- pretrained on millions to billions of images -- have been reported to improve generalization performances on various downstream tasks. However, it has not been systematically assessed whether they fully eliminate batch effects. In this study, we empirically show that the feature embeddings of the foundation models still contain distinct hospital signatures that can lead to biased predictions and misclassifications. We further find that the signatures are not removed by stain normalization methods, dominate distances in feature space, and are evident across various principal components. Our work provides a novel perspective on the evaluation of medical foundation models, paving the way for more robust pretraining strategies and downstream predictors.
△ Less
Submitted 8 November, 2024;
originally announced November 2024.
-
AI-based Anomaly Detection for Clinical-Grade Histopathological Diagnostics
Authors:
Jonas Dippel,
Niklas Prenißl,
Julius Hense,
Philipp Liznerski,
Tobias Winterhoff,
Simon Schallenberg,
Marius Kloft,
Oliver Buchstab,
David Horst,
Maximilian Alber,
Lukas Ruff,
Klaus-Robert Müller,
Frederick Klauschen
Abstract:
While previous studies have demonstrated the potential of AI to diagnose diseases in imaging data, clinical implementation is still lagging behind. This is partly because AI models require training with large numbers of examples only available for common diseases. In clinical reality, however, only few diseases are common, whereas the majority of diseases are less frequent (long-tail distribution)…
▽ More
While previous studies have demonstrated the potential of AI to diagnose diseases in imaging data, clinical implementation is still lagging behind. This is partly because AI models require training with large numbers of examples only available for common diseases. In clinical reality, however, only few diseases are common, whereas the majority of diseases are less frequent (long-tail distribution). Current AI models overlook or misclassify these diseases. We propose a deep anomaly detection approach that only requires training data from common diseases to detect also all less frequent diseases. We collected two large real-world datasets of gastrointestinal biopsies, which are prototypical of the problem. Herein, the ten most common findings account for approximately 90% of cases, whereas the remaining 10% contained 56 disease entities, including many cancers. 17 million histological images from 5,423 cases were used for training and evaluation. Without any specific training for the diseases, our best-performing model reliably detected a broad spectrum of infrequent ("anomalous") pathologies with 95.0% (stomach) and 91.0% (colon) AUROC and generalized across scanners and hospitals. By design, the proposed anomaly detection can be expected to detect any pathological alteration in the diagnostic tail of gastrointestinal biopsies, including rare primary or metastatic cancers. This study establishes the first effective clinical application of AI-based anomaly detection in histopathology that can flag anomalous cases, facilitate case prioritization, reduce missed diagnoses and enhance the general safety of AI models, thereby driving AI adoption and automation in routine diagnostics and beyond.
△ Less
Submitted 21 June, 2024;
originally announced June 2024.
-
xMIL: Insightful Explanations for Multiple Instance Learning in Histopathology
Authors:
Julius Hense,
Mina Jamshidi Idaji,
Oliver Eberle,
Thomas Schnake,
Jonas Dippel,
Laure Ciernik,
Oliver Buchstab,
Andreas Mock,
Frederick Klauschen,
Klaus-Robert Müller
Abstract:
Multiple instance learning (MIL) is an effective and widely used approach for weakly supervised machine learning. In histopathology, MIL models have achieved remarkable success in tasks like tumor detection, biomarker prediction, and outcome prognostication. However, MIL explanation methods are still lagging behind, as they are limited to small bag sizes or disregard instance interactions. We revi…
▽ More
Multiple instance learning (MIL) is an effective and widely used approach for weakly supervised machine learning. In histopathology, MIL models have achieved remarkable success in tasks like tumor detection, biomarker prediction, and outcome prognostication. However, MIL explanation methods are still lagging behind, as they are limited to small bag sizes or disregard instance interactions. We revisit MIL through the lens of explainable AI (XAI) and introduce xMIL, a refined framework with more general assumptions. We demonstrate how to obtain improved MIL explanations using layer-wise relevance propagation (LRP) and conduct extensive evaluation experiments on three toy settings and four real-world histopathology datasets. Our approach consistently outperforms previous explanation attempts with particularly improved faithfulness scores on challenging biomarker prediction tasks. Finally, we showcase how xMIL explanations enable pathologists to extract insights from MIL models, representing a significant advance for knowledge discovery and model debugging in digital histopathology. Codes are available at: https://github.com/bifold-pathomics/xMIL.
△ Less
Submitted 7 January, 2025; v1 submitted 6 June, 2024;
originally announced June 2024.
